December 13, 2024

Joint research on the next generation of sun screens

Joint research on the next generation of sun screens

The German Cancer Research Center (DKFZ) and Beiersdorf are cooperating on the development of innovative sun protection products – and are working together to educate people about effective protection against harmful UV radiation.

Experts predict that climate change and the associated increase in the number of hours of sunshine will lead to a further increase in skin cancer cases. This is particularly to be expected for non-melanoma skin cancer, which is diagnosed around 210,000 times in Germany every year. This term covers squamous cell carcinomas and basal cell carcinomas. Both are considered to be the result of harmful sun exposure. They mainly develop on the skin’s so-called “sun terraces” that are intensely exposed to UV radiation, such as the forehead, nose or ears.

Consistent sun protection can prevent the development of cancer – but what actually happens in the skin when we forget to apply sunscreen? Which molecular processes are triggered by sun exposure in the skin – and how can they possibly be reversed? How does the skin regenerate after sunburn and can it be specifically supported by special substances? And do people with different skin types also need different sun protection that takes into account the respective biological properties of the skin cells?

The DKFZ and Beiersdorf will join forces to research these innovative issues in the future. A newly signed research cooperation agreement has now set the seal on the collaboration, which is initially planned for three years. The aim of the two partners is to develop the next generation of sun screens and care products that support the regeneration of sun-damaged skin in jointly selected research projects. In the best case scenario, this could prevent the development of malignant cells.

Furthermore, the two partners will develop joint campaigns to educate people about the correct use of sunscreen and set up a research clinic for individualized skin cancer prevention at the National Cancer Prevention Center.

“Research into cancer prevention is one of the DKFZ’s core tasks. In the research collaboration with Beiersdorf, we are taking a dual approach: on the one hand, we are focusing on molecular strategies such as the development of agents that prevent healthy cells from developing into skin cancer as a result of UV damage,” says Michael Baumann, Chairman and Scientific Director of the DKFZ. “On the other hand, we want to support people in protecting themselves as best as possible from harmful UV radiation.”

“I am very pleased that our successful collaboration with the DKFZ is continuing. Since 2008, we have been able to decode many secrets of the skin in various projects and contribute to the rapidly growing body of knowledge around skin aging and maintaining skin health,” explains Gitta Neufang, Chief Research & Development Officer at Beiersdorf, adding, “In the more than 140 years of our company history, sun protection has always played an important role. Now, we want to use our expertise and increased education to make an important contribution to counteracting the increase in skin cancer.”

The DKFZ and Beiersdorf are funding the projects for three years with a total of €3.6 million. The two institutions have been closely linked for many years through joint research projects. The cooperation in the field of skin cancer prevention and innovative sun screen is a logical continuation of the successful collaboration.

Our latest News

discover more
Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg with 16 “Highly Cited Researchers”

International evaluation names researchers whose publications have been most cited worldwide 16 researchers from Heidelberg University feature on the recently published list of “Highly Cited Researchers”. This international evaluation names researchers whose publications have been cited most frequently worldwide in their respective field or who have an outstanding track-record of publications across several disciplines. The […]

Universität Heidelberg: New DFG Research Unit in Oncology

Universität Heidelberg: New DFG Research Unit in Oncology

GenoMiCC consortium deals with functional genomics and microbiomics in colorectal cancer and is coordinated at the Medical Faculty Mannheim In the latest approval round of the German Research Foundation (DFG), Heidelberg University has been successful with a grant application for a new Research Unit in oncology. The GenoMiCC consortium pursues the goal of identifying new […]

Merck and Promega collaborate on 3D cell technology for drug discovery

Merck and Promega collaborate on 3D cell technology for drug discovery

Full text in German below. Merck und Promega arbeiten gemeinsam an 3D-Zelltechnologie für die Wirkstoffforschung Strategische Partnerschaft bündelt Know-how von Merck im Bereich Organoide mit Promegas Assay-TechnologienForschende erhalten besseren und schnelleren Zugang zu krankheitsrelevanten ZellmodellenStärkt Mercks Position bei zukunftsweisenden Tools und Lösungen auf dem Gebiet der Biologie Darmstadt, Deutschland. (06. November 2025) Merck, ein führendes Wissenschafts- […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp